Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.

DiGiandomenico A, Warrener P, Hamilton M, Guillard S, Ravn P, Minter R, Camara MM, Venkatraman V, Macgill RS, Lin J, Wang Q, Keller AE, Bonnell JC, Tomich M, Jermutus L, McCarthy MP, Melnick DA, Suzich JA, Stover CK.

J Exp Med. 2012 Jul 2;209(7):1273-87. doi: 10.1084/jem.20120033. Epub 2012 Jun 25.

3.

Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa.

Tam VH, Schilling AN, Neshat S, Poole K, Melnick DA, Coyle EA.

Antimicrob Agents Chemother. 2005 Dec;49(12):4920-7.

4.

Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa.

Tam VH, Schilling AN, Melnick DA, Coyle EA.

Diagn Microbiol Infect Dis. 2005 Jun;52(2):145-51.

PMID:
15964503
5.

Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents.

Tam VH, Schilling AN, Lewis RE, Melnick DA, Boucher AN.

Antimicrob Agents Chemother. 2004 Nov;48(11):4315-21.

6.

Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus.

Gross PA, Asch S, Kitahata MM, Freedberg KA, Barr D, Melnick DA, Bozzette SA.

Clin Infect Dis. 2000 Apr;30 Suppl 1:S85-93. Review. Erratum in: Clin Infect Dis 2000 May;30(5):841. Bozette SA [corrected to Bozzette SA].

PMID:
10770917
7.

Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease.

Kenney RT, Kwon-Chung KJ, Waytes AT, Melnick DA, Pass HI, Merino MJ, Gallin JI.

Clin Infect Dis. 1992 Jan;14(1):235-42.

PMID:
1571438
8.

In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.

Rex JH, Bennett JE, Gallin JI, Malech HL, DeCarlo ES, Melnick DA.

J Infect Dis. 1991 Apr;163(4):849-52.

PMID:
1901332
9.

Invasive infection with Sarcinosporon inkin in a patient with chronic granulomatous disease.

Kenney RT, Kwon-Chung KJ, Witebsky FG, Melnick DA, Malech HL, Gallin JI.

Am J Clin Pathol. 1990 Sep;94(3):344-50.

PMID:
2396608
10.

Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease.

Margolis DM, Melnick DA, Alling DW, Gallin JI.

J Infect Dis. 1990 Sep;162(3):723-6.

PMID:
2117627
11.

Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae.

Rex JH, Bennett JE, Gallin JI, Malech HL, Melnick DA.

J Infect Dis. 1990 Aug;162(2):523-8.

PMID:
2165113
13.
14.

Effects of recombinant human granulocyte-macrophage colony-stimulating factor on intracellular pH in mature granulocytes.

Sullivan R, Griffin JD, Wright J, Melnick DA, Leavitt JL, Fredette JP, Horne JH Jr, Lyman CA, Lazzari KG, Simons ER.

Blood. 1988 Nov;72(5):1665-73.

15.

Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.

Pothoulakis C, Sullivan R, Melnick DA, Triadafilopoulos G, Gadenne AS, Meshulam T, LaMont JT.

J Clin Invest. 1988 Jun;81(6):1741-5.

17.
18.

Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes.

Sullivan R, Griffin JD, Simons ER, Schafer AI, Meshulam T, Fredette JP, Maas AK, Gadenne AS, Leavitt JL, Melnick DA.

J Immunol. 1987 Nov 15;139(10):3422-30.

PMID:
3119708
19.
20.

The effects of phorbol myristate acetate and chemotactic peptide on transmembrane potentials and cytosolic free calcium in mature granulocytes evolve sequentially as the cells differentiate.

Sullivan R, Melnick DA, Malech HL, Meshulam T, Simons ER, Lazzari KG, Proto PJ, Gadenne AS, Leavitt JL, Griffin JD.

J Biol Chem. 1987 Jan 25;262(3):1274-81.

21.
23.
24.

A transient rise in intracellular free calcium is not a sufficient stimulus for respiratory burst activation in human polymorphonuclear leukocytes.

Apfeldorf WJ, Melnick DA, Meshulam T, Rasmussen H, Malech HL.

Biochem Biophys Res Commun. 1985 Oct 30;132(2):674-80.

PMID:
3933507
26.

Functional integrity of cytokineplasts: specific chemotactic and capping responses.

Dyett DE, Malawista SE, Van Blaricom G, Melnick DA, Malech HL.

J Immunol. 1985 Sep;135(3):2090-4.

PMID:
2991379
27.

Biochemical analysis and subcellular localization of a neutrophil-specific antigen, PMN-7, involved in the respiratory burst.

Melnick DA, Nauseef WM, Markowitz SD, Gardner JP, Malech HL.

J Immunol. 1985 May;134(5):3346-55.

PMID:
3156932
28.

An antibody to a subpopulation of neutrophils demonstrates antigenic heterogeneity which correlates with response heterogeneity.

Seligmann B, Malech HL, Melnick DA, Gallin JI.

Trans Assoc Am Physicians. 1984;97:319-24. No abstract available.

PMID:
6085529

Supplemental Content

Loading ...
Support Center